Gut dysbiosis and multiple sclerosis

Area of Science:

• Neuroimmunology
• Microbiome Research
• Autoimmune Disease Pathogenesis

Background:

• Multiple sclerosis (MS) is a central nervous system (CNS) inflammatory and autoimmune disease.
• T cell-mediated autoimmune processes are implicated in MS pathogenesis.
• Gut microbiota dysbiosis is increasingly associated with autoimmune conditions, including CNS diseases.

Purpose of the Study:

• To review recent findings on the association between gut microbiota and MS.
• To discuss the role of microbiota in CNS autoimmune diseases.
• To explore microbiota function in animal models of MS.

Main Methods:

• Literature review of recent studies.
• Analysis of evidence linking gut microbiota composition to MS.
• Examination of microbiota function in experimental autoimmune encephalomyelitis (EAE) models.

Main Results:

• Evidence suggests a significant association between gut microbiota dysbiosis and MS.
• Alterations in gut bacteria impact the host immune system, influencing CNS autoimmunity.
• Microbiota modulation shows potential in MS animal models.

Conclusions:

• The gut microbiota plays a crucial role in the development and progression of MS.
• Targeting the gut microbiota represents a promising therapeutic avenue for MS.
• Further research into the gut-brain axis in MS is warranted.